|
Q Fever Diagnostic Serology
|
|
General
|
| |
Clinical Use:
|
Diagnostic testing for Coxiella burnettii infection (Q fever). All specimens are screened with qualitative C. burnettii phase 2 IgG enzyme immunoassay and qualitative IgM indirect fluorescent antibody test (IFA). Specimens with detectable phase 2 IgG have supplementary testing with phase 2 IgG IFA which is reported as a titre. Specimens with a high phase 2 IgG titre have further testing with phase 1 IgG IFA, reported as a titre. Specimens may be referred to Pathology West, NSW, for phase 1 IgA IFA testing if required, provided phase 1 IgG titres are high. |
| |
Availability:
|
Samples are batched and tested twice a week. |
| |
Aliases/Synonyms:
| Coxiella burnetii Diagnostic Serology , Coxiella burnetii Pre-Vaccination Serology, Q Fever Pre-Vaccination Serology, |
| |
Code:
|
SEQFV |
| |
Handling Instructions (to laboratory):
|
Send sample chilled. |
| |
Hyperlink:
|
|
| |
Reference Interval:
|
Refer to report or laboratory
|
Collection Requirements
|
| |
Container:
|
Serum Sep. Tube-SST (GOLD), |
| |
Sample Type:
|
See container |
| |
Minimum Collection Volume:
|
3mL |
| |
Collection Instructions:
|
|
Processing Requirements
|
| |
Alternate Containers:
|
|
|
|
|
Serum, no gel (RED) |
| |
Processing Instructions:
|
|
| |
Minimum Assay Volume:
|
1mL |
| |
Stability:
|
2 days chilled |
| |
Transport Instructions (to testing laboratory):
|
Send sample chilled. |
Testing Locations
|
| |
Performed at:
|
|
Section
|
Department
|
Site
|
Contact Phone
|
| Serology |
Microbiology |
QEII Medical Centre |
6383 4427 |
|
Last Updated : 07-10-2025 11:59 |